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Ergogenic L-citrulline and malate are amino acids used in specific combination to
effect muscular endurance during athletic performances. Purpose: The study aimed to
investigate the ergogenic properties of citrulline-malate (CM) during a resistance training
protocol. Methods: Utilizing a randomized, counterbalanced, double blind study, fifteen
trained males completed a resistance training protocol once using placebo (PL) and once
with CM (8.0g). Results: CM supplementation increased repetitions in chin-ups, reverse
chin-ups, push-ups, and total trial repetitions. Blood lactate was significantly increased
post-exercise compared to pre-exercise, but was not significantly different between CM
and placebo. Further, a significant interaction effect was revealed for systolic blood
pressure, a significant condition effect for diastolic blood pressure, and a significant time
effect for HR. Post-hoc analysis revealed that SBP responses were more elevated in the
placebo condition during recovery. Conclusion: Collectively, these novel findings
suggest CM increases muscular endurance during upper body resistance exercise.
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CHAPTER I
INTRODUCTION

For as long as there have been competitive sports, there has been a desire by the
participants of their respective sports to utilize the most of their potential to give them
any form of advantage over their counterparts. Logically the first step was to adopt the
right training regimen to correlate with an increased performance in competition. The
next step was to develop ways to get the most out of the adopted training regimen to
further increase the performance benefits shown during competition. A number of
methods have been tested ranging from simply modifying the individual’s diet by
increasing or decreasing certain nutrients to more novel and complex methods such as
blood boosting (Leigh-Smith 2004) or gene mapping that determines which genes
correlate with specific attributes which is still only being tested with animals (Huson et
al. 2010). Within the last several decades of the 20th century and today’s society use of
nutritional ergogenic aids are receiving the most attention and have become a popular
way to improve training and ultimately competitive performance among athletes
(Thein,Thein, and Landry 1995, Applegate and Grivetti 1997).
The term “ergogenic aid” encompasses a large spectrum of techniques and
methods used to enhance performance. Anything such as: a training method, specific
diet, mechanical device, pharmacological substances, or psychological preparation that is
used with the intention of improving performance in training and/or competition in sport
1

can be considered an ergogenic aid (Kreider et al. 2010). Nutritional and some
pharmacological ergogenic aids can be considered as dietary supplements that include but
are not limited to: multivitamins, creatine, and sports foods/drinks (Tian, Ong, Tan 2009).
Use of nutritional/pharmacological ergogenic aids probably stemmed from simply from
supplementing different aspects of an individual’s normal diet with certain foods. These
supplemented foods were used to add extra nutrients such as: carbohydrates, vitamins,
minerals, amino acids/proteins, metabolites, or some form of combination of these
nutrients that would fuel or improve performance in the activity or sport the individual
participated in (Williams 2004). However, as technology improved over time the
nutrients were manufactured into dietary supplements. These supplements claim to
enhance performance, increase energy, maintain strength and health, and limit nutritional
deficiencies by adding larger doses of desired nutrients to the diet in the form of tablets,
powders, or liquids as needed by the individual to meet the demands of their specific
activity/sport (Heikkinen et al. 2011). Some nutritional aids, especially those utilizing
proteins/amino acids, are considered pharmacological aids because they mimic some of
the effects of other pharmacological aids like anabolic steroids (Silver 2001).
In recent years, a new dietary supplement has begun to gain popularity among
strength and power athletes ranging from professional bodybuilders to recreational
strength athletes. Originally, citrulline-malate mixtures were developed as a treatment
for asthenia, however in recent decades, its perceived benefits on performance has also
led to its use as a pre-exercise dietary supplement (Bendahan et al. 2002, Pérez-Guisado
and Jakeman 2010 . The term citrulline-malate comes from the components L-citrulline,
which is a non-essential amino acid, and malate, which is a derivative of malic acid
2

(Schwedhelm et al. 2007, Zelle et al. 2008). This combination of citrulline and malate
was developed to be the active ingredient of this supplement. Like creatine or the various
protein/amino acid supplements on the market, citruline-malate is believed to enhance
training by sustaining muscle force and work and delaying the effects of fatigue on the
muscle (Pérez-Guisado and Jakeman 2010). Only a limited amount of research has been
done on this supplement and the exact physiological mechanisms by which this
supplement is believed to work are still in question. Some research even questions if this
product works at all and if it does work is this merely due to a placebo effect. The
purpose of this study was to test the effectiveness of citruline-malate on muscular
performance and prevention of muscular fatigue and potentially observe the exact
mechanisms by which citruline-malate improves these factors during exercise.
Statement of the Problem
Will muscular endurance be augmented as a result of ingestion of citrullinemalate prior to engaging in an acute bout of resistance exercise focusing on muscular
endurance?
Hypotheses
HO1: There is no significant difference in blood lactate (BLa) between citrullinemalate and placebo (PL) treatments in male participants
HO2: There is no significant difference in heart rate (HR) between citrullinemalate and PL treatments in male participants.
HO3: There is no significant difference in blood pressure (BP) between citrullinemalate and PL treatments in male participants.
3

HO4: There is no significant difference in resistance training performance
between citrulline-malate and PL treatments in male participants.
Basic Assumptions
1. Participants understood all directions given to them.
2. Participants followed the directions given to them.
3. Subjects did not participate in any strenuous exercise training 48 hours
prior to testing.
4. Measurements were accurately performed on measured equipment.
5. Participants were non-supplement using participants.
6. Participants performed the given exercise to volitional failure.
Limitations
Potential limitations of this study:
1. Athletes were not tested for steroid use.
2. Nutrient intake may not have been repeated correctly due to each
participant monitoring his food intake 48 hours prior to testing.
Delimitations
1. Most participants were in the traditional college age range of 18-22
2. Participants were recreationally trained lifters.
3. Participants selected had more than 6 months of consistent training at the
time of testing
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Definitions
1. Muscular fatigue: a decrease in the force generation of a working muscle
across time.
2. Exhaustion or Failure: inability to complete one repetition due to muscular
fatigue.
3. Anaerobic Muscular Endurance: maximum amount of repeated
contraction repetitions of a muscle or muscle group sustained over a
period time, yet does not utilize aerobic metabolic pathways as a primary
source of energy.
Significance of the Study
In most competitive sports, especially in more elite levels, a matter of seconds or
inches can be the difference between victory and defeat. For an athlete having enough
muscular endurance to sustain the desired level of muscular performance in order to last
longer or go further than their opponent is the true testament to their training. Many
athletes seek to acquire the optimal benefits of their training by ingesting supplements,
such as citrulline-malate, that will intensify the quality of their training. The
examinations of this study will hopefully augment the modest body of literature in
regards to the effects of citrulline-malate on muscular endurance.
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CHAPTER II
REVIEW OF LITERATURE

According Dale Ahrendt, M.D., in 1996 a study showed approximately 50% of
the United States’ general population reported some use of supplementation and other
studies showed 76% of collegiate athletes and 100% of bodybuilders took supplements
(Ahrendt 2001). Through the years numerous supplements claiming to utilize various
ingredients to improve muscular performance have been used by professional and
amateur athletes alike. As time goes by, some supplements are no longer used due to a
belief they are not effective or because they may be too effective and have been deemed
unfair and illegal in professional sports. No matter the reason, the fall of one supplement
inevitably makes room for the rise of another. Currently products like GAKIC are
gaining popularity for their perceived influence of enhancing muscular endurance and
helping sustain overall muscular performance. Muscular endurance is generally
described as the muscle’s/muscles’ ability to sustain repeated contractions over extended
periods of time. To understand the importance of sustaining repeated contractions and
their benefit to overall performance, it is important to have a thorough understanding of
the mechanisms that interact to generate a single contraction. In addition it is necessary
to understand the different aerobic and anaerobic metabolic processes that supply the
energy needed to produce these muscular contractions. Both developers and consumers
of the various ergogenic supplements should have a thorough understanding of these
6

pathways when making judgments on the validity of the effectiveness of these
supplements on muscular contractions, muscular endurance, and overall muscular
performance.
Utilization of Aerobic and Anaerobic Metabolism
The body produces energy for metabolic processes in a number of ways; however
no matter which pathway is used each pathway can be described as being aerobic or
anaerobic in nature. Whether aerobic or anaerobic, the energy for metabolic processes is
supplied by the degradation and synthesis of the molecule adenosine triphosphate (ATP).
ATP is considered the main currency of energy in all living organisms (Cloutier and
Wellstead 2010). The differences between the two are the substrates used in the
processes and whether or not oxygen is used to break these substrates down.
Aerobic Metabolism
Oxidation is the process by which oxygen (02) interacts with and removes an
electron (e-) from another substance. Aerobic metabolism employs 02 to break down, or
oxidize, fat (for fatty acids) and carbohydrates (for glucose) which are the primary
substrates of aerobic ATP synthesis in skeletal muscle (Ergen et al. 2005). Inside skeletal
muscle cells the double-membrane organelles known as mitochondria synthesize ATP by
removing hydrogen molecules (H+) and e-‘s from pyruvate and fatty acids which
ultimately are by-products from the breakdown of fats and carbohydrates (Scott 2005).
The metabolic process responsible for the removal of H+ and e- from pyruvate and fatty
acids is known at the Kreb’s Cycle. O2 inside the inner membrane of the mitochondria
attracts e-‘s in what is known as an electron transport chain, and this chain is used to
7

pump H+ from higher concentrations to lower concentrations which creates an energy
gradient (Scott 2005). The energy from this gradient produced in the mitochondria is
used in the re-synthesis of ATP, and the overall process is referred to as oxidative
phosphorylation. Endogenous triglycerols are a large fuel reserve of the body and are
stored mostly in the adipose tissues (fat) of the body but small amounts are also found in
skeletal muscle (Horowitz and Klein 2000). Fat is the primary fuel source during lower
intensity exercise as well as the primary source of fatty acids, which makes aerobic
metabolism more relevant to endurance athletes who perform at lower intensities for an
extended period of time (Horowitz and Klein 2000, Scott 2005).
Anaerobic Metabolism
Compared to other metabolic processes of the body oxidation of fats is a slow
process. Strength and power athletes perform at moderate to high intensities for short
periods of time which means aerobic metabolism would only have a minimal influence
on energy production for these individuals. Anaerobic metabolism requires minimal
oxygen since the main two energy systems utilized by strength and power athletes are the
phosphagen system and the glycolytic system which do not require oxygen to resynthesize ATP (Baker, McCormick, and Robergs 2010). The energy supplied at the
beginning of any form of exercise is the creatine-kinase system. This is the two-way
system, which is part of the phosphagen system. H+ can be added to phosphocreatine
(PCr) and adenosine diphosphate and then catalyzed by creatine-kinase to yield to ATP
and a molecule of creatine (CR). The reverse can also occur where creatine-kinase can
breakdown ATP and yield ADP and PCr. The creatine-kinase system is an important
buffer of ATP when there is a change in energy demand such as going from rest to
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exercise (Thompson et al. 1996). Within a few seconds of exercise the creatine-kinase
system gives way to anaerobic glycolysis, which is the breakdown of glucose without the
presence of 02. Glycolysis utilizes glucose in the blood and glycogen, the stored form of
glucose in skeletal muscle, to re-synthesize ATP (Baker, McCormick, and Robergs
2010). During glycolysis glucose is broken down in a series of enzymatic reactions and a
small amount ATP is resynthesized in a process that can be considered as a substrate
level phosphorylation (Scott 1996). Depending on the rate H+ and e-‘s are released from
glucose, glycolysis can result in the production of pyruvate or lactate. If H+ and e-‘s are
released at a rate equivalent to the current rate of aerobic metabolism in the mitochondria,
H+ enters the mitochondria of skeletal muscle cells and pyruvate is the byproduct of
glycolysis; however if H+ and e-‘s are released at a rate that exceeds aerobic metabolism
the H+ binds with pyruvate and ultimately lactate is the byproduct of glycolysis (Scott
1996). The end product of lactate is of concern because excessive buildup of lactate
makes the pH of the muscle too acidic and results in fatigue and ultimately the inability
of the muscle to continue to contract.
Muscle Contraction
Expression of skeletal muscles' mechanical capacity is demonstrated by the
muscles' ability to exert force, shortening, and by combinations of force exertion and
shortening (Rahe-Meyer et al. 2008). Skeletal muscles' ability to shorten and exert forces
are vitally important to basic life functions and even more so if individuals intend to
engage in physical activity/exercise and participate in competitive sports. Voluntary
muscle contractions are initiated by electrical impulses that travel from the central
nervous system (CNS) to the peripheral nervous system (PNS) and then the muscle.
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Motor units, which are the neurons and the muscle fibers they innervate, interpret the
intensity of impulses and regulation of these impulses determines the number of fibers to
be recruited which correlates to the force of the contraction (Duchateau and Enoka 2008).
Once the fibers are recruited, calcium ions (Ca2+) are released from the sarcoplasmic
reticulum as a result of what is known as an action potential. The intracellular release of
Ca2+ from the sarcoplasmic reticulum triggers the mechanical aspects of a muscular
contraction (Kim et al. 2006). The Ca2+ released from the sarcoplasmic reticulum
interacts with troponin, which is attached to the protein tropomyosin that is part of the
thin myofilament actin. Binding with Ca2+ alters the position of tropomyosin and
exposes the binding sites located on the actin filament (Vingradova et al. 2005). Once
the binding sites are exposed, the sperm-like globular heads of the the thick myofilament,
myosin, extend and bind to the now exposed binding sites on the actin filament (Hooper,
Hobbs, and Thuma 2008). The binding of the globular heads of myosin to actin results in
a discrete lever arm of rotation powered by ATP, which is believed to cause myosin to
move the actin filament (Jackson and Baker 2009). This belief of a thick myofilament
sliding along a thin filament was proposed within the last century and is known as the
sliding-filament theory of muscle contractions (Vinogradova et al. 2005). Inability to
sustain adequate repetitions of this process over time results in what is considered as
muscular fatigue.
Muscular Fatigue
Muscular fatigue can be considered a transient decrease in the ability to perform
physical actions resulting from a number of factors including: reduction in muscular
force, exhaustion of contractile muscle function, acidosis of the muscle and even the
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psychological decline of mental function (Enoka and Duchateau 2008). The
physiological aspects of muscular fatigue could also be the result of the energy pathways
of the body not producing enough adenosine triphosphate, or ATP, to supply the energy
needed to continue muscular contractions and overall activity. This supports the notion if
the energy supply does not meet the energy demands imposed on the working muscle
during physical activity then muscular fatigue will be the inevitable outcome (Barclay,
Arnold, and Gibbs 1995). It appears that muscle fatigue cannot simply be described as
resulting from a single factor, but instead a combination of physiological and
psychological factors.
Physiological Fatigue
A study conducted by David Jones, published in The Journal of Physiology in
2010, observed the relationship between force and velocity in fatigued muscle. His study
supported the belief a cause of fatigue in working skeletal muscle is the loss of the
muscle's ability to produce force. Jones compared the contraction of a fresh quadriceps
muscle to a fatigued quadriceps muscle and noticed a significant decrease in power. The
decrease in power was a result of a combination of a 20-30% decrease in force as well as
velocity in the fatigued muscle. In order to apply this to anaerobic activity, Jones
described this decrease in power as the reason runners struggle to maintain their speed in
the last 100 meters of a 400m sprint or individual's rapid reduction in power output at the
end of a Wingate Test. Acidosis of the muscle, which is a commonly believed to cause
fatigue, was alluded to in this study. It was stated in this study that acidosis plays a
minimal effect on fatigue because a previously observed patient with McArdle's disease,
who did not produce the byproducts that lead to acidosis, still showed the characteristic
11

loss of force associated with fatigue. From this study, changes in contractile properties
and issues with the cross bridge mechanisms of the myofilaments seem to correlate more
with loss of force and fatigue rather than acidosis (Jones 2010).
Exhaustion of contractile properties of muscle is also a viable presumption in
when explaining the cause of fatigue. As stated by Jones, de Ruiter, and de Haan in their
study published in 2006, two contractile properties could be contributors to muscular
fatigue. They recognized the slowed process of removing Ca2+ from muscle, or the
reduction in the speed in which myosin cross bridges detach from actin filaments could
lead to inadequate muscle function and decrease in muscular performance (Jones, de
Ruiter, and de Haan 2006). Though it was unclear as to what extent rate of Ca2+
removal played in fatigue, a primary finding of this study was that the slowed relaxation
of fatigued muscle correlated with changes in cross-bridge function (Jones, de Ruiter, and
Haan 2006).
Psychological Fatigue
More novel approaches not only acknowledge the physiological factors of fatigue,
but are now starting to recognize the potential psychological and neurological factors as
well. Studies like the study published by Noakes, St. Clair Gibson, and Lambert in 2005
examines these novel approaches to fatigue that incorporate these factors. Agreeing with
Jones' 2010 study, Noakes, St. Clair Gibson, and Lambert also put little emphasis on
acidosis playing a major role during fatigue in muscle. However, where Jones' 2010
study uses physiological evidence to support their statement, Noakes, St. Clair Gibson,
and Lambert state acidosis instead leads to an increase in perception of discomfort. This
perception of discomfort supports psychological factors' influence on fatigue. The
12

authors also take a novel approach to the effect of ATP on fatigue. It is widely accepted
that depletion of ATP is responsible for the decline in contractions over time; however,
the authors state that even during the most intense exercise ATP stores never drop to less
than 50% of their resting values. This interpretation of ATP presumes that, like acidosis,
ATP may play a smaller role in fatigue than previously believed. As stated in this study,
older beliefs look at physiological factors or "peripheral events" as the cause of fatigue
and minimize psychological and neurological influences. Yet the reverse may be true
and peripheral events may play a lesser role in comparison to these psychological and
neurological influences. The central governor model states that exercise performance is
centrally regulated and that influence of the central nervous system(CNS) changes the
perspective of fatigue from physiological to more of an emotion or feeling (Noakes, St.
Clair Gibson, and Lambert 2005). This article supports the notion that defining fatigue
cannot be limited to only physiological factors.
Muscle Fiber Type
Just as there different energy pathways in the body that are utilized during
different exercise intensities and durations, there are different muscle fibers in the body
whose usage depends on the same conditions of exercise. Human skeletal muscle can be
classified into two primary types: fatigue-resistant slow twitch fibers known as type-I
fibers or fatigue-sensitive fast twitch fibers known as type-II fibers (Baguet et al. 2011).
Type-II fibers can be further divided into subgroups: type-IIa, type-IIx, and type-IIb
(Casas et al. 2008).

13

Type-I Fibers
Type-I muscle fibers have been characterized as "slow-twitch" because the twitch
force they generate takes approximately four times longer to generate than type-II fibers
(Macdonald and Stephenson). These muscle fibers are of great significance to physical
activity/exercise that lasts for longer duration and rely on more aerobic pathways for
production of ATP. It has been shown that muscles composed primarily of the highly
oxidative type-I fibers contain a high mitochondrial density and are utilized more during
prolonged repetitive activity (Grifone et al. 2004, Casas et al. 2008). Skeletal muscles of
athletes participating in exercise/sports that are more aerobic in nature, such as marathons
and triathlons, usually are comprised of more type I fibers.
Type-II and Intermediate Fibers
Type-II fibers are characterized as fast-twitch fibers in the body. As stated
earlier, they are able to produce a twitch force much faster than their type-I counterparts.
Athletes, whose physical activity involves more intermittent bursts over shorter periods
of time, utilize muscles that have a lower mitochondrial density and contain more
glycolytic type-II fibers (Grifone 2004, Casas et al. 2008). It was also stated earlier in
this section that type-II fibers could be further classified into smaller and more specified
phenotypes: type-IIa, type-IIx, and type-IIb. Type-IIb fibers characteristically have
significantly less mitochondria and rely primarily on anaerobic energy pathways in
comparison to type-I fibers; whereas type-IIa and type-IIx fibers have oxidative
capacities valued somewhere between those of type-I and type-IIb fibers (Casas et al.
2008). Type-IIb fibers can be considered opposite in nature to type-I fibers, and typesIIa/IIx can be considered as intermediates between the two. Skeletal muscles of athletes
14

participating in exercises that are anaerobic or more anaerobically dominant in nature,
such as power-lifters, 100m sprinters, or soccer players, tend to be comprised more of the
type-II muscle fiber phenotypes.
Metabolic Dynamics
Onset of exercise causes the body to shift from a state of storing energy to a state
of utilizing energy. This shift is the result of nueruoendocrine changes, contraction of
working muscles, and redistribution of blood flow primarily to the working muscles
(Younk et al. 2011). Nueroendocrine changes triggered by the autonomic aspect of the
peripheral nervous system

influence the delivery of muscle substrates and change the

normal distribution of the blood (Helge et al. 2007). Once these neuroendocrine changes
are initiated changes in heart rate, utilization of glucose, and production of lactate can
occur.
Heart Rate
Heart rate is the amount of time the heart beats per min and is a factor cardiac
output, which is the amount of blood pumped out by the heart per minute. As an
individual goes from rest or light exercise to more intense physical activity, both heart
rate and cardiac output increase resulting from circulation of norepinephrine and
epinephrine released by the neuroendocrine system (Snyder, Johnson, and Joyner 2008).
Increases in heart rate allows for a higher cardiac output. The increased cardiac output
supplies more blood to the working muscle since blood flow is directed away from areas
with lesser need for oxygen and directed to working muscles, which require more oxygen
(Snyder, Johnson, and Joyner 2008). At the time of this increase in heart rate and cardiac
15

output, glucose is released from the liver and is transported by the blood to the working
muscles to be broken down for energy (Goodwin 2010).
Glucose
As stated in the aerobic and anaerobic metabolism section of the current review,
break down of glucose is the primary fuel source for early and more intense physical
activity/exercise. The initial source of fuel for working muscle is its own stores of
glucose in the form of glycogen (Younk et al. 2011). However, these glucose stores
deplete quickly and other fuel sources are required to continue the physical
activity/exercise. By the time the muscles' glycogen stores have been depleted blood
glucose becomes the primary fuel source for muscles, through anaerobic glycolysis, until
more aerobic pathways take over. Glucagon, an enzyme produced by pancreatic cells,
initiates glucongenolysis and gluconeogenesis in the blood to provide a new supply of
glucose to working muscle (Younk et al. 2011).
Lactate
Glycogenolysis, breakdown of glycogen, and glycolysis, breakdown of glucose
yield the byproduct lactate (Service 1991, Scott 1996). Higher intensity exercises, which
use anaerobic glycolysis as a primary fuel source, cannot be sustained over extended
periods of time due to the higher concentrations of lactate they produce (Lewis et al.
2010). As mentioned earlier in the aerobic and anaerobic metabolism section of the
current review, lactate, a byproduct of glycolysis, makes the environment of the working
muscle more acidic. In the muscle fatigue section of the current review it was referenced
that this lactate-induced acidosis correlates physiologically by a highly acidic
16

environment and psychologically by perceptions of discomfort. Both aspects of fatigue
lead to a decrease in muscular endurance and overall performance.
Performance Enhancing Substances
There is a vast array of performance enhancing substances (PES's) that claim to
improve athletic performance by increasing strength gains, reducing the effects of
muscular fatigue, promoting faster recovery from injury, improving body mass index, and
increasing level of focus during exercise (Buckman et al. 2009). In a 1997 study it was
documented that Americans spent approximately $11.8 billion on supplements and it was
predicted that this amount would continue to increase in the following years (Ahrendt
2001). Many PES's have been vilified and their use has become illicit in more elite levels
of sports; however use of these substances are still common among athletes of various
skill levels (Buckman et al. 2009). With an abundant number of substances, many whose
effects have been minimally researched, the line between which substances' usage should
be considered licit or illicit is very thin.
Illicit PES's
When it comes to illicit PES's, substances that are synthesized versions of
hormones that occur naturally in the human body are the most recognized with anabolicandrogenic steroids (AAS's) being the most popularly discussed (Hoffman 2002). These
substances can be administered orally or injected directly into the blood stream (Thein,
Thein, and Landry 1995). The term anabolic refers to "tissue building" and androgenic
refers to "masculinizing" (Thein, Thein, and Landry 1995). AAS's are synthetic versions
of testosterone and have been shown anabolically to provide large increases in muscle
17

mass and further promote protein synthesis (Thein, Thein, and Landry 1995, Hoffman
2002, Kanayama, Hudson and Pope 2010). As appealing as these physiological effects
may be to athletes, evidence supporting adverse effects on the body such as sterility in
males, increased stress to the cardiovascular system, increased aggression, and
development of mood disorders has increased the infamy of AAS usage (Thein, Thein,
and Landry 1995, Hoffman 2002, Kanayama, Hudson and Pope 2010). Due to the extent
of their effectiveness many deem their usage as cheating and offensive to the true "spirit
of competition" (Savulescu, Foddy, and Clayton 2004). A combination of dangerous
adverse effects and being associated with cheating are the reason AAS's are the most
infamous illicit PES's.
Licit PES's
Dietary supplements, some that are anabolic in nature, have also been
manufactured to enhance performance. Popular dietary supplements contain active
ingredients such as: creatine, various vitamins, stimulants, nitrous oxide and
protein/amino acids (Silver 2001, Kersick and Leutholtz 2005). Creatine has been
associated with increases in muscular performance by enhancing intracellular ATP and is
used to enhance anaerobic athletes' training (Silver 2001, Tokish, Kocher, and Hawkins
2004). Nitrous oxide is naturally present in the body and is shown to aid in vasodilation.
Nitrous oxide supplement manufacturers have claimed their products enhance
performance by increasing blood flow to working muscles by increasing the amount of
nitrous oxide in the body (Bloomer et al. 2010). Proteins, which are composed of amino
acids, are the building blocks of muscles and there are numerous protein/amino acid
supplements on the market. According to studies analyzing the effectiveness of protein
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supplements, there is strong evidence that supports administering protein/amino acid
supplements during periods of rest and post-exercise aid in increasing protein balance and
synthesis in skeletal muscle (Kersick and Leutholtz 2005). Dietary may or may not have
as the same adverse side effects as AAS's. Due to the numerous available dietary
supplements and steady introduction of new supplements, these ergogenic aids are
deemed safe or licit until adverse effects are reported in scientific/medical literature
(Kreider et al. 2010).
Citrulline-Malate
Active Ingredients
As mentioned earlier in this paper, citrulline-malate is a combination of the nonessential amino acid L-citrulline and malate. In humans L-citrulline is converted to Largininosuccinate and by ensuing metabolic processes it becomes L-arginine
(Schwedhelm et al. 2007). L-arginine is used in the synthesis of nitric oxide, which
promotes vasodilation of the smooth muscle found in blood vessels (Bloomer 2010). The
importance of malate in the citrulline-malate mixture is in its use as an intermediate in the
Kreb's cycle (Pérez-Guisado and Jakeman 2010). The Kreb's cycle utilizes malateasparate and malate-citrate shuttle pathways to transfer electrons. The malate-asparate
shuttle facilitates transfer of electrons from the cytoplasm of the cell to the mitochondrial
matrix, which helps regulate glycolysis and lactate oxidation (Lu et al. 2008). However,
once the number of electrons transported by this shuttle becomes too low, lactate is no
longer oxidized and begins to accumulate.
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Functions
It has already been mentioned that citrulline-malate has been utilized as a
treatment for asthenia, which is a medical term generally used to describe energy loss or
weakness. As a treatment for asthenia, citrulline-malate has been shown to improve
muscle performance in subjects suffering from weakness and fatigue associated with this
condition (Bendahan et al. 2002). The improvements in muscle performance seen in
these individuals in relation to use of citrulline-malate has led to interest in its potential
ergogenic effectiveness among a healthy and more athletic population. As an ergogenic
aid, citrulline-malate may potentially improve muscle performance by: facilitating
clearance of ammonium which is a factor in fatigue, limiting lactic acid accumulation,
and increasing nitric oxide production (Pérez-Guisado and Jakeman 2010). Ingestion of
citrulline-malate, in regards to its use as an ergogenic aid, should be conducted orally
prior to exercise. As a pre-exercise supplement, it is recommended to ingest citrullinemalate in 4-10 g doses 1 hour prior to exercise/competition (Pérez-Guisado and Jakeman
2010). Oral ingestion at the proper dosages is preferred because it has been observed to
increase plasma concentrations of both L-arginine and L-citrulline, which facilitates a
correlating enhancement in nitric oxide-dependent signaling (Schwedhelm et al. 2007).
The enhancements in nitric oxide signaling will lead to increases in nitric oxide and its
function as a vasodilator of blood vessels. Theoretically, in regards to ergogenic
increases in nitric oxide, further increases in vasodilation will facilitate optimal blood
flow and superior delivery of oxygen and nutrients to working muscle (Bloomer 2010).
Optimal oxygen and nutrient delivery in combination with the attrition of fatigue
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resulting in enhanced performance potentially makes citrulline-malate an effective preworkout supplement.
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CHAPTER III
METHODOLOGY

Participants
Male participants, preferably within the traditional college age range of 18 to 22,
were recruited for this study. To qualify, potential participants were required to have a
minimum of six months of continuous strength training. Participants were free of any
medical conditions, which may hinder their ability to perform the exercise protocol.
Prior to participating in the study, participants were required to complete health history
questionnaires and sign a statement of informed consent. Patients who reported having
not used anabolic steroids for at least one year prior to participation in the investigation
were qualified for this experiment. Potential participants not meeting these criteria were
eliminated from this investigation. The procedures outlined were reviewed and approved
by the Institutional Review Board at Mississippi State University.
Pre-Testing Evaluation
During the initial session, participants were provided with an explanation of the
informed consent and research protocol (Day 1). Informed consent was signed prior to
any evaluations on the participant. On day one, all anthropometric measurements were
determined. Participants' standing height, body weight, and body fat percent was
assessed. Standing height and body weight was assessed using a Doctor's scale
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(Healthometer 402EXP). Participants removed their shoes and stood erect with their
hands down at their side in an erect position. Heels were placed together. The
measurement stick was placed at the center of the participants' head at the highest point.
Participants were weighed in shorts without shoes. Body weights were measured in
kilograms. Body fat percentages were determined using the 3-site skinfold method
described by Pollack and Wilmore (1990).
Experimental Protocol (Session 2 & 3)
Each participant performed the trials a minimum of one week apart, in which the
experimental treatments, citrulline-malate (CM) or placebo (PL), were randomly assigned
and administered in a double-blind fashion. Upon arriving to the Sanderson Center
weight room on the campus of Mississippi State University, the participants were taken to
a designated area and given the treatment designated prior to their arrival. Fifty minutes
after ingesting the treatment, the participant's heart rate (HR) and resting blood lactate
levels (BLa) were measured. Heart rate and blood pressure (BP) were assessed using an
automated blood pressure monitor (SunTech Medical Cycle). Blood lactate (BLa) was
assessed by taking blood samples from the finger sticks from the participants and samples
were immediately analyzed using the Lactate Pro Analyzer.
After these measurements were obtained, the participants remained seated until
the total time proceeding ingestion of the treatment was 60 minutes. The time from
ingestion to the beginning of the workout, including pre-workout measurements, was
exactly 60 minutes. This period allowed adequate time for the supplement to be absorbed
by the body's system.
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Participants completed three sets each of chin-ups (hands pronated), reverse chinups (hands supinated), and push-ups to failure with 3 minutes of rest between each set.
The order of the exercises were the same for each session and all participants.
Participants waited on a "go" command at the initial hanging position beginning at full
elbow extension for each chin-up and reverse chin-up repetition. The repetition was
counted if the chin reached a parallel level with the bar. A tester held their arm in front
of the participant to prevent excessive swinging of the participant's body. Markings were
placed on the apparatus to ensure the same hand position is maintained during each trial
and set. The participant's push-up repetitions were counted if the participant's chest made
contact with the tester's fist, which rested on the ground beneath the participant's nipple
line. Participant's elbows were fully extended after the concentric portion of the
repetition. Failure for either exercise was defined as the inability to complete a full
repetition without assistance. This protocol was used as a measure of muscular
endurance. BLa was immediately assessed within 5 seconds of the final push-up
repetition. HR and BP were measured at five minutes and ten minutes following the last
push-up repetition.
Experimental Design
Treatment order was randomly assigned to participants. A double-blind crossover
design was used, as neither the principal investigators nor the participants were aware of
the treatment order. The treatments were placed in small plastic bags marked with either
a red or black dot. Experimental days were separated by a minimum of 1 week but no
more than 2 weeks to minimize participant fatigue.
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Dietary and Supplement Intake
Participants completed a 24-hour diet and exercise recall during the 60 min preexercise period of each experimental trial. Participants were also restricted from taking
any medications or supplements 48 hours prior to each trial, and participants were also
asked to abstain from intense exercise within the 48 hours preceding each trial. Those
individuals who failed to acknowledge meeting these criteria during the phone call
preceding the test were rescheduled. Rescheduling was dependent on testing availability
and washout period.
Treatment Ingestion
Over-the-counter CM or a PL were provided to participants 60 minutes preexercise. The CM or PL will be administered to the participants mixed in 300 mL of
chilled crystal light lemonade juice. This drink was administered in one full dose 60
minutes prior to exercise. The amount of CM ingested by all participants was
approximately 8 grams in accordance with recommended dosages being between 4-10
grams (Pérez-Guisado and Jakeman 2010). Seven days later, participants ingested the
alternative treatment, and repeated the identical exercise protocol. There have been no
reported side effects of CM when taken in recommended amounts by the manufacturer or
cited in prior literature.
Statistical Analysis
Performance differences for resistance exercises were analyzed using 2 (trial) x 3
(time) repeated measures analyses of variance (RMANOVAs). Paired t-tests were used to
determine significant differences for total trial repetitions and total repetitions per
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exercise (set 1 + set 2 + set 3). One way ANOVA and paired t-tests were used to
determine differences between conditions as appropriate. Statistical analyses were
performed using commercially available software (SPSS Inc., Chicago, IL, USA) and
acceptance for statistical significance was p ≤ 0.05.
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CHAPTER IV
RESULTS

Participants
This study consisted of fifteen apparently healthy, resistance trained male
participants (see Table 1).
Table 1

Demographic data for subjects
Variable

Mean ± SD

Age (yrs.)

23.73 ± 2.28

Height (cm)

178.91 ± 6.73

Weight (kg)

86.91 ± 9.37

Body fat %

15.73 ± 4.95

Resistance Performance
Analyses of performance on the resistance exercises (pull-ups, reverse pull-ups,
and push-ups) demonstrated similar responses across all three exercises. No significant
interaction effect was seen for the resistance exercises, although all three exercises
demonstrated a significant main effect for condition (pull-ups: F1, 14 = 13.49, p = .003;
reverse pull-ups: F1, 14 = 9.64, p = .008; and push-ups: F1, 14 = 27.04, p = .001), with
the CM condition resulting in greater number of total repetitions performed in each
exercise between the two groups (Figure 1). The total number of repetitions for each
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exercise and complete session was calculated by adding the repetition sum of all
individual exercises and the trial collectively (Figure 2).

Figure 1

Chin-up, reverse chin-up, and push-up repetitions (group) performed
collectively were significantly greater in the CM than PL group

(# indicates p < 0.05).
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Figure 2

Mean (± SD) total repetitions for exercise and complete trial

*Significantly different (p < 0.05) between trials.
Blood Lactate
Blood lactate values demonstrated a significant increase from pre- to postexercise in both conditions (treatment t14 = 27.14, p > .001; control t14 = 15.44, p >
.001). No differences were shown between conditions either prior to or after exercise,
thus demonstrating no significant differences in lactate responses as a result of
supplementation (Figure 3).
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Figure 3

Blood lactate (mmol/l) at PRE and POST (i.e. following the exercise
protocol).

No differences between trials were found.
Cardiovascular Variables
Repeated measures analysis of cardiovascular variables (HR, SBP, and DBP)
demonstrated a significant interaction effect for SBP (F2, 28 = 4.70, p = .02), a
significant main effect for condition for DBP (F1, 14 = 13.15, p = .003), and a significant
time main effect for HR (F2, 27 = 100.55, p < .001). Post-hoc analysis revealed that SBP
responses were more elevated in the placebo condition at R5 (t14 = 3.28, p = .005) and
R10 (t14 = 3.74, p = .002). These results suggest that the CM supplement did have an
impact on cardiovascular responses during the resistance exercise, although the
mechanisms by which these responses occurred needs to be further investigated (Figure
4).
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Figure 4

SBP and DBP (group) for Pre-Exercise and Recovery 5 and 10 minutes
post-exercise.

*Indicates p < 0.05 between various time points.
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CHAPTER V
DISCUSSION

The purpose of this investigation was to investigate the effects of citrulline-malate
(CM) on resistance exercise performance (i.e. number of repetitions performed), blood
lactate, blood pressure, and heart rate during repeated bouts of upper body exercises in
resistance trained college-age male subjects. In this study, we hypothesized that CM
supplementation would not effect the number of repetitions performed by trained males
during a nine set upper body exercise session.
Implications
The results in our investigation are in agreement with a prior study (PerezGuisado and Jakeman 2010) that investigated the effects of CM supplementation on
resistance exercise performance. Specifically, Perez-Guisado and Jakeman reported that a
single dose of CM (8 g) increased performance by an average of 19%, measured as the
number of repetitions performed until exhaustion occurred. Additionally, the authors
reported a significant decrease of 40% in muscle soreness by subjects during their CM
trial 24 and 48 hours following their resistance training session.
The precise mechanism by which CM leads to an increase in resistance exercise
performance remains elusive, however, several have been proposed: 1) citrulline
detoxifies ammonia , 2) alters the acid base balance, in particular lactic acid formation, 3)
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increases plasma L-arginine concentrations (Hickner et al. 2006), while 3) malate acts as
a metabolic shuttle between the cytoplasm and mitochondria by mitigating lactic acid
accumulation and enabling continued pyruvate genesis, synergistically 4) increasing the
availability of ATP (Bendahan et al. 2002) and nitric oxide via NO synthases catalytic
effects on L-arginine and oxygen (Weissman and Gross 2001).
Nitric oxide (NO) is a gaseous molecule that plays an important role in many
functions in the body including vasodilatation regulation, blood flow, and mitochondrical
respiration. Additionally, NO regulates glucose uptake and oxidation,
mitochondriogenesis, and other contractile functions in skeletal muscle (Petrovic et al.
2008). Availability of plasma arginine to endothelial cells is a limiting factor for NO
synthesis (Nussler 1994). Citrulline supplementation increases levels of plasma Larginine (Hickner et al. 2006); thereby, augmenting plasma arginine concentrations
following exercise (Goodwin, Solomonson, and Eichler 2004, Mori 2007). Finally,
malate affects oxidative ATP production through anaplerotic reations (Gibala, Young,
and Taegtmeyer 2000), which mitigates ammonia’s blockade of the oxidative pathway,
therefore continuing pyruvate genesis (latic acid ↔ pyruvate).
In prior studies, (Bescos et al. 2012) authors speculated that CM would impact
metabolic pathways. Specifically, lactic acid is quickly dissociated (loses a hydrogen)
into a molecule called lactate, which is constantly being produced in humans at both rest
and during exercise (Brooks 2009, Donovan and Brooks 1983, Hashimoto and Brooks
2008). Blood lactate concentrations can range from a resting value of 1 mmol/kg of
muscle to more than 25 mmol/kg during intense exercise (Kilding and Jones 2005, Kon et
al. 2010). In our study, blood lactate increased following both trials; however, there was
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no significant difference in blood lactate between the CM and placebo treatments. This
suggests that CM does not have a positive or negative influence lactate production in the
glycolytic system.
An acute bout of resistance exercise can significantly increase heart rate and
blood pressure, especially if the individual uses the Valsalva maneuver. Peak heart rate of
170 beats per minute and blood pressures of 320/250 mmHg have been reported during
high intensity lower body exercise (MacDougall et al. 1985). The present study
confirmed a rise in heart rate, DBP, and SBP between pre and post-exercise for both
treatments. There were no differences between treatments in heart rate; however, SBP
and DBP were significantly lowered during the CM treatment. This may have been
attributed to a vasodilatory effect mediated by NO due to the activity of nitric oxide
synthase (Orozco-Gutierrez et al. 2010).
In closing, the current study supports previous literature and agrees the use of
citrulline-malate (CM) as a pre-workout supplement would be advantageous to
performance. The exact mechanisms by which CM would improve performance are still
not clear. However, from the results of the current study, evidence of improved
cardiovascular conditions seen during the CM treatment is a likely mechanism. The
current study focused on the use of CM in a more anaerobic setting. Future research
following a more aerobic protocol may provide further support and novel findings to
explain improvements in performance after ingestion of CM.
Recommendations for Future Research
Future research of citrulline-malate (CM) could test alternative variables such as:
1. Use of a more aerobic protocol.
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2. Administration of CM in pill form versus powder
3. Testing ingestion of CM in multiple dosages over the course of days or
"loading" versus an acute ingestion prior to exercise.
4. Monitoring additional biomarkers such as blood glucose.
5. Testing highly trained and elite athletes.
6. Testing and older age group.
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PARTICIPATION AND HEALTH HISTORY QUESTIONNAIRE
Complete each question accurately. All information provided is strictly confidential.
Part I: Participant Information
Name (Print)

Home Phone #

Current Mailing Address

Cell Phone #

Personal Physician

Email Address

Emergency Contact (relationship)

Emergency Contact Phone #

Gender:
Height

Female

Male

Date of Birth:

Weight

Age

Part II. Health History
List any physical injuries or limitations that you have at this time:

Have you ever been diagnosed as having any cardiovascular abnormalities?
No

Yes

If yes, what was diagnosed and when was the diagnosis conducted?

Please circle any of the following for which you have been diagnosed or treated by a
physician, health care professional, or which you have experienced personally:
Heart Attack
Heart Palpitations
Shortness of Breath
Heart Valve Problems
Heart Murmur
Fainting

Bypass Surgery
Sickle-Cell Anemia
Arrhythmia
Chest Pain
Stroke
Anemia
Seizure
Hypoxemia
Heart Rhythm Abnormalities
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Do you have or have had any form of respiratory (breathing) ailments in the previous
three months? Please circle those that apply.
Asthma
Emphysema

COPD
Bronchitis

Common cold
H1N1 flu

Have you been diagnosed with any of the following? If yes, please circle the appropriate
ailment.
Rheumatic Fever

High Blood Pressure

Obesity

Kidney/Liver Disease

High Cholesterol

Diabetes

Hemophilia

Multiple Sclerosis

Other_____________________________________________________________
Does anyone in your family have any of the conditions listed above? If yes, please list
relation to family member and problem:

Is your mother living?

Yes

No (age at death

; cause

)

Is your father living?

Yes

No (age at death

; cause

)

Do you have any allergies (latex, food, drug, etc.)?

Yes

No

If yes, please list:

Have you ever performed a one repetition muscular strength tests?

Yes

No

****If yes, when and what were the latest results (bench press and/or leg press)?

Have you ever experienced any adverse responses during or after exercise (i.e. dizziness,
difficulty breathing, racing heart beat, fainting)?
Yes
No
If yes, what were the symptoms?

Part III. Health Related Behavior
Do you smoke?

YES

No
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If yes, indicate number of cigarettes per day?
Less than ½ a pack
1 pack
Do you drink alcohol?

YES

Greater than 1 pack

No

IF YES, INDICATE NUMBER OF ALCOHOLIC BEVERAGES PER WEEK?
Less than 10
10
GREATER THAN 10
Do you exercise regularly (30 minutes, 3 times per week)?

Yes

No

If so, what exercises do you participate in regularly?

Are you taking any medications (prescription/nonprescription) or supplements?
Yes

No

If yes, please list:

Have you ever heard of the supplement Citrulline Malate, prior to the introduction to this
research project? _____ YES _____NO
If YES,
Where?_____________________________________________________________
If YES, have you ever taken the supplement Citrulline Malate? _____ YES _____NO
If YES, please indicate time usage of the supplement:
____ week (7 days or less)
____ 9 months
____ month (4 weeks or less)
____ 12- 18 months
____ 3 months
____ 2 years
____ 6 months
____ 3 years
Other (please explain-______________________________________________________
What supplement(s) (ergogenic aid for weightlifting) have you cycled on (6 weeks or
longer) in your past?
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Check all that apply:
___GAKIC
___NO explode
___Glycerol
___Ephedrine/Ephedra
enhancers (pro-hormones)

___Protein Powder
___Citrulline Malate
___Caffeine
___Wt. loss products

___Creatine
___NOS drinks/pills
___Sodium Bicarbinate
___Natural testosterone

Other (please
list)____________________________________________________________________
_____
Are you taking Citrulline Malate or any other supplement at the moment time? ____ YES
____NO
If YES, are you willing to discontinue usage during this experimental
protocol? ___Yes ___NO

Thank You
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